Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
-
* Corresponding author: Hans-Juergen Thiesen hans-juergen.thiesen@med.uni-rostock.de
Arthritis Research & Therapy 2008, 10:R50 doi:10.1186/ar2419
Accesses
- Last 30 days: 64 accesses
- Last year: 734 accesses
- All time: 4592 accesses
Cited by
BioMed Central: 7 citations
|
Review
Advances in rheumatology: new targeted therapeutics Paul P Tak, Joachim R Kalden Arthritis Research & Therapy 2011, 13(Suppl 1):S5 (25 May 2011) |
|
Research article
Bertalan Mesko, Szilard Poliska1, Andrea Szegedi, Zoltan Szekanecz, Karoly Palatka, Maria Papp, Laszlo Nagy BMC Medical Genomics 2010, 3:15 (5 May 2010) |
|
Research article
Mayte Suárez-Fariñas, Kejal R Shah, Asifa S Haider, James G Krueger, Michelle A Lowes BMC Dermatology 2010, 10:1 (12 February 2010) A genomic classifier using the expression of 23 genes in peripheral blood mononuclear cells gives a preliminary prediction of whether patients with psoriasis will respond to Alefacept treatment.
|
|
Methodology article
Integrative modeling of transcriptional regulation in response to antirheumatic therapy Michael Hecker, Robert Goertsches, Robby Engelmann, Hans-Juergen Thiesen, Reinhard Guthke BMC Bioinformatics 2009, 10:262 (24 August 2009) |
|
Editorial
Predicting the future of anti-tumor necrosis factor therapy Cornelis L Verweij Arthritis Research & Therapy 2009, 11:115 (22 June 2009) |
|
Research article
Cuong Q Nguyen, Ashok Sharma, Byung Ha Lee, Jin-Xiong She, Richard A McIndoe, Ammon B Peck Arthritis Research & Therapy 2009, 11:R56 (20 April 2009) |
|
Review
Transcription profiling of rheumatic diseases Lisa GM van Baarsen, Carina L Bos, Tineke Pouw Kraan, Cornelis L Verweij Arthritis Research & Therapy 2009, 11:207 (30 January 2009) This article is part of a collection on The Scientific Basis of... |